Unipres (5949) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Mar, 2026Executive summary
Net sales for Q3 FY2025 were ¥225,122 million, down 4.8% year-over-year, mainly due to customer production cuts and foreign exchange impacts.
Operating profit rose to ¥6,749 million, up 131% year-over-year, driven by reduced depreciation costs and streamlining.
Ordinary profit increased 71.9% to ¥7,286 million year-over-year.
Net income attributable to owners of parent was ¥205 million, up 89.8% year-over-year.
Comprehensive income for the quarter was ¥6,301 million, compared to a loss of ¥2,779 million in the prior year.
Financial highlights
Net sales: ¥225,122 million (down 4.8% year-over-year).
Operating profit: ¥6,749 million (up 127.5% year-over-year).
Ordinary profit: ¥7,286 million (up 71.9% year-over-year).
Net income per share was ¥4.62, compared to ¥2.43 in the previous year.
Equity ratio improved to 46.2% from 44.8% at the end of the previous fiscal year.
Outlook and guidance
Full-year FY2025 net sales forecast at ¥295,000 million, with operating income projected at ¥9,000 million and ordinary income at ¥9,000 million.
Net income attributable to owners of parent expected to be negative ¥4,500 million.
No revisions to previously announced forecasts.
FY2025 projections remain unchanged; net sales and operating income expected to decline from the previous year due to ongoing production cuts and forex effects, despite cost reductions.
Latest events from Unipres
- Operating profit rose despite lower sales, but net income was hit by one-time losses and FY2025 outlook is cautious.5949
Q4 202512 Mar 2026 - Operating profit and net income surged despite a 7.3% sales decline; outlook remains strong.5949
Q2 202612 Mar 2026 - Q1 FY2024 profits surged, with net income up 30% and strong full-year earnings guidance.5949
Q1 202512 Mar 2026 - Sharp declines in Q3 sales and profit led to a downward revision of full-year forecasts.5949
Q3 202512 Mar 2026 - First-half profits rose, but full-year outlook was cut amid lower demand and higher costs.5949
Q2 202512 Mar 2026 - Sales dropped 8.2% but operating profit and net income rose; full-year outlook remains cautious.5949
Q1 202612 Mar 2026